Gene-edited rice can produce a compound that's vital for human health
A team of Chinese scientists has used targeted gene editing to develop rice that produces coenzyme Q10 (CoQ10), a vital ...
FierceBiotech18h
Allogene’s phase 1 lymphoma data show CAR-T could ‘leapfrog’ competition: analysts
Two months after Allogene abandoned plans for its CAR-T in leukemia, analysts have suggested that fresh phase 1 data in ...
IN8bio presented Phase 1 data on INB-100 at 2025 TCT
IN8bio (INAB) presented Phase 1 data on its allogeneic gamma-delta T cell therapy, INB-100, at the 2025 Transplantation & Cellular Therapy, ...
IN8bio Presents Positive Phase 1 Data at TCT 2025, Highlighting Durability of Remissions in High-Risk AML
IN8bio is accelerating patient enrollment in the INB-100 program and expects to complete enrollment of the expansion cohort in 2025. The company’s FDA discussions confirmed that relapse-free survival ...
precisionmedicineonline16h
BC Cancer Foundation Launches C$6.8M Campaign to Advance CAR T-Cell Therapies
The foundation hopes to put the funds toward two clinical programs in blood cancers and one preclinical project in solid tumors.
Johns Hopkins Medicine3d
The Immortal Life of Henrietta Lacks
The donation of Henrietta Lacks' cells began what was the first, and, for many years, the only human cell line able to reproduce indefinitely. Her cells, known as HeLa cells for Henrietta Lacks, ...